Content related to CHLA Joins CureWorks Collaborative to Accelerate Development of Immunotherapy Treatments for Childhood Cancers

With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.

A state-of-the-art cell therapeutics facility will support the translation of novel cell therapy and tissue engineering approaches into clinical testing for a wide range of human diseases.

The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat

In 2018, Children’s Hospital Los Angeles was the first hospital in Southern California approved to deliver a new therapy to pediatric patients with acute lymphoblastic leukemia that did not respond to